Skip to main content

Table 2 Clinical response, anti-TERT response and immunosuppressive cells in all patients (n = 29)

From: Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood

  1. Abbreviations: HN Head & neck cancer, SCC Squamous cell carcinoma, NSCLC Non-small cell lung cancer, SCLC Small cell lung cancer, RT Radiotherapy, CT Chemotherapy, OR Objective response, PD Progressive disease, TERT Antitumor response, C Cisplatin, CE Cisplatin + etoposide, CN Cisplatin + navelbine, CP Carboplatin + paclitaxel. Δ: evolution of anti-TERT response, Treg and MDSC rates after CRT, defined as stability (), increase () or decrease (). (+) sign represents presence of anti-TERT response, (−) sign represents absence of anti-TERT response